HB
HERVE BRAILLY Président
CHAIRMAN M
FR FR · AMF
€450,558
▼ Sales (21 ops.)
Browse the full record of transactions filed by HERVE BRAILLY, Président. Insider active across 1 companies, notably Innate Pharma. In total, 25 reports have been recorded. Total volume traded: €451k. The latest transaction was filed on 17 June 2022 (Cession). Regulator: AMF. All data is accessible without signup.
Declarations 25 total
€23,970 10,000 shares @ €2.397 0.016% mcap 32.2% of flow FR0010331421⌘
2022DD850530 · 17 Jun 2022
€25,517 10,000 shares @ €2.5517 0.017% mcap 34.2% of flow FR0010331421⌘
2022DD850535 · 30 Jun 2022
€25,055 10,000 shares @ €2.5055 0.017% mcap 33.6% of flow FR0010331421⌘
2022DD849422 · 23 Jun 2022
€24,795 10,000 shares @ €2.4795 0.017% mcap 2.4% of flow FR0010331421⌘
2022DD847925 · 15 Jun 2022
€29,100 10,000 shares @ €2.91 0.019% mcap 2.8% of flow FR0010331421⌘
2022DD847585 · 10 Jun 2022
€29,100 10,000 shares @ €2.91 0.019% mcap 2.8% of flow FR0010331421⌘
2022DD846559 · 9 Jun 2022
€20,244 7,000 shares @ €2.892 0.013% mcap 2.0% of flow FR0010331421⌘
2022DD846557 · 7 Jun 2022
€29,230 10,000 shares @ €2.923 0.019% mcap 2.8% of flow FR0010331421⌘
2022DD846558 · 8 Jun 2022
Executives ● apport de titres à la société Kervrant Biotech SASI Innate Pharma 13 AMF €133,500 30,000 shares @ €4.45 0.089% mcap 12.9% of flow FR0010331421⌘
Action Hors plateforme de négociation2022DD817969 · 28 Jan 2022
€55,000 10,000 shares @ €5.50 0.037% mcap 5.3% of flow FR0010331421⌘
2021DD773273 · 29 Sept 2021
€265,200 130,000 shares @ €2.04 0.18% mcap 25.6% of flow FR0010331421⌘
Option d'achat Euronext Paris2021DD767831 · 9 Aug 2021
€102,000 50,000 shares @ €2.04 0.068% mcap 9.8% of flow FR0010331421⌘
Option d'achat Euronext Paris2021DD766561 · 30 Jul 2021
€159,559 49,095 shares @ €3.25 15.4% of flow FR0010331421⌘
Action Donation - opération hors marché ne dionnant pas2021DD760059 · 12 Jun 2021
€5,309 1,405 shares @ €3.7783 0.0035% mcap 0.5% of flow FR0010331421⌘
2021DD738884 · 29 Mar 2021
€13,193 3,500 shares @ €3.7695 0.0088% mcap 1.3% of flow FR0010331421⌘
2021DD738882 · 26 Mar 2021
€13,077 3,500 shares @ €3.7364 0.0087% mcap 1.3% of flow FR0010331421⌘
2021DD738881 · 25 Mar 2021
€13,214 3,500 shares @ €3.7753 0.0088% mcap 1.3% of flow FR0010331421⌘
2021DD738337 · 24 Mar 2021
€13,403 3,500 shares @ €3.8294 0.0089% mcap 1.3% of flow FR0010331421⌘
2021DD738336 · 23 Mar 2021
€15,207 4,000 shares @ €3.8017 0.010% mcap 1.5% of flow FR0010331421⌘
2021DD738335 · 22 Mar 2021
€12,850 3,500 shares @ €3.6713 0.0086% mcap 1.2% of flow FR0010331421⌘
2021DD738334 · 19 Mar 2021
€14,205 3,500 shares @ €4.0586 0.0095% mcap 1.4% of flow FR0010331421⌘
2021DD732509 · 10 Feb 2021
€20,226 5,100 shares @ €3.9659 0.013% mcap 2.0% of flow FR0010331421⌘
2021DD732508 · 11 Feb 2021
€14,205 3,500 shares @ €4.0586 0.0095% mcap 1.4% of flow FR0010331421⌘
2021DD731721 · 10 Feb 2021
€29,394 7,400 shares @ €3.9722 0.020% mcap 2.8% of flow FR0010331421⌘
2021DD731720 · 9 Feb 2021
€24,264 6,400 shares @ €3.7913 0.016% mcap 2.3% of flow FR0010331421⌘
2021DD731719 · 5 Feb 2021
About HERVE BRAILLY HERVE BRAILLY is an executive at INNATE PHARMA.